Approval and access: Overcoming the final hurdle of drug development
pharmaphorum
MARCH 10, 2017
2017 is once again a year of significant change for pharma market access in Europe, with affordability on the agenda for almost every country in the region. There is a move toward greater collaboration in health technology assessment and more transparency between countries for pricing, therapeutic protocols and and details of negotiations with drug manufacturers.
52 
Let's personalize your content